Global Cancer Pain Market

Global Cancer Pain Market Size, Share, Growth Analysis, By Drug(Opioids, Morphine), By Disease Indication(Lung Cancer, Colorectal Cancer) - Industry Forecast 2023-2030


Report ID: SQMIG35J2075 | Region: Global | Published Date: February, 2024 | Pages: 157 | Tables: 71 | Figures: 65

Global Cancer Pain Market Insights

Cancer Pain Market size was valued at USD 6.2 billion in 2021 and is poised to grow from USD 6.55 billion in 2022 to USD 10.12 billion by 2030, growing at a CAGR of 5.6% in the forecast period (2023-2030).

The expansion of the global cancer pain market is primarily propelled by factors including the growing cancer prevalence, an aging population, increased healthcare spending, and augmented research and development efforts by healthcare enterprises.

In 2020, for instance, the American Cancer Society reported approximately 1.8 million new cancer cases and around 606,520 cancer-related deaths in the U.S. Colorectal cancer saw about 1,065,960 new cases worldwide that same year, according to the International Agency for Research on Cancer.

Older individuals are more susceptible to various cancers due to age-related effects and genetic mutations. The National Cancer Institute indicates median diagnosis ages of 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer, and 66 for prostate cancer.

US Cancer Pain Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 6.2 billion

Largest Segment

Lung Cancer

Fastest Growth

Lung Cancer

Growth Rate

5.6% CAGR

Global Cancer Pain Market ($ Bn)
Country Share for North America Region (%)
Global Cancer Pain Market By Disease Indication ($ Bn)
Global Cancer Pain Market By Disease Indication (%)

To get more reports on the above market click here to Buy The Report

Global Cancer Pain Market Segmental Analysis

The global cancer pain market is segmented on the basis of drug type, disease indication, region. By drug type, the market is segmented into opioids, morphine, fentanyl, others, non-opioids, acetaminophen, non-steroidal anti-inflammatory drugs (nsaids), nerve blockers. By disease indication, the market is segmented into lung cancer, colorectal cancer, breast cancer, prostate cancer, blood cancer, others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Cancer Pain Market Analysis By Drug Type

In 2022, the market was largely led by the opioids segment, a trend projected to persist during the forecast period. This dominance is attributed to the growing prevalence of intense cancer-related pain, the escalating use of opioids for cancer pain management, and a robust pipeline of such drugs. Conversely, the non-opioids sector is anticipated to experience significant market expansion in the forecast period due to factors such as the widespread availability and cost-effectiveness of these medications.

The opioids category's stronghold can be attributed to the increasing incidence of severe cancer-related pain and the growing adoption of opioids as a primary method of pain management. The presence of a strong pipeline for opioid-based drugs is further bolstering this segment's prominence. Conversely, the non-opioids division is poised for substantial growth due to factors like the ready accessibility of these drugs, making them an attractive option for mild to moderate cancer pain cases. Additionally, the cost-effectiveness of non-opioid medications adds to their appeal and is anticipated to contribute significantly to their market traction during the forecast period.

Cancer Pain Market Analysis By Disease Indication

In 2022, the cancer pain market was largely steered by the lung cancer segment, and this dominance is projected to endure over the forecast period. The prevailing influence of this segment can be attributed to several factors, including the rising prevalence of lung cancer cases, a heightened occurrence of pain linked to lung cancer, and the availability of efficacious analgesics tailored to address the specific pain associated with this type of cancer.

Lung cancer's preeminence in driving the market is driven by its escalating prevalence and the inherent pain challenges accompanying the disease. The substantial pain experienced by lung cancer patients has underscored the demand for targeted pain management strategies, making this segment a prominent driver of the market. Additionally, the development of specialized analgesics that effectively target the unique pain patterns associated with lung cancer has further solidified the segment's dominant position.

Conversely, the breast cancer segment is poised for significant market growth during the forecast period. This projection can be attributed to the increasing prevalence of breast cancer, a commonly diagnosed malignancy among individuals. The adoption of pain analgesics in breast cancer treatment regimens has gained traction owing to the substantial discomfort often experienced by patients. As a result, the breast cancer segment is expected to witness noteworthy expansion, driven by the imperative to alleviate pain and enhance the overall quality of life for breast cancer patients through targeted pain management interventions.

Global Cancer Pain Market By Disease Indication, 2021 (%)

To get detailed analysis on other segments, Request For Sample Report

Global Cancer Pain Market Regional Insights

In 2022, North America played a pivotal role in the cancer pain market, capturing a substantial share, and this influential position is anticipated to persist throughout the forecast period. The region's continued prominence is underpinned by several factors including the escalating prevalence of cancer cases, continuous technological advancements in the healthcare sector, the convenient accessibility of pain management therapies, and the availability of top-tier chemotherapy treatment options. These factors collectively contribute to North America's stronghold in driving the growth of the cancer pain market.

Notably, Asia-Pacific is projected to exhibit the highest CAGR of 6.0%. This robust growth trajectory is attributed to multiple factors that are transforming the landscape of cancer pain management in the region. The rapid increase in cancer prevalence within Asia-Pacific has necessitated an augmented focus on effective pain management solutions. Furthermore, the region is experiencing a surge in its elderly population, a demographic more prone to cancer incidence, which further emphasizes the demand for advanced pain management interventions. Additionally, a heightened awareness pertaining to the importance of early cancer screening has gained momentum, contributing to the increased demand for pain management strategies. These combined forces are driving Asia-Pacific's impressive growth in the cancer pain market, making it a significant contender in shaping the future of cancer pain management.

Global Cancer Pain Market By Geography, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Cancer Pain Market Dynamics

Cancer Pain Market Drivers

Advancements in Medical Technology

  • Technological innovations in pain management techniques, drug delivery systems, and personalized treatments enhance the efficacy and accessibility of cancer pain management.

Increased Healthcare Expenditure

  • Higher healthcare spending allows for better access to pain management therapies and treatments, fostering market growth.

Cancer Pain Market Restraints

Adverse Effects of Pain Medications

  • The potential for drug tolerance, dependence, and various side effects associated with pain medications can limit market growth.

Stigma Around Opioid Use

  • Concerns over opioid misuse and addiction may hinder the widespread adoption of opioid-based pain management strategies.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Cancer Pain Market Competitive Landscape

The competitive landscape of the global cancer pain market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative solutions for effective pain management. Established players such as Pfizer, Johnson & Johnson, Purdue Pharma, and Novartis maintain a strong presence, leveraging their extensive research capabilities and product portfolios. These companies often collaborate with medical institutions to advance pain management technologies and therapies.

The market also witnesses the emergence of smaller, specialized firms like Heron Therapeutics, who focus on developing novel drug delivery systems and non-opioid alternatives. Technological advancements, personalized treatment approaches, and telemedicine integration are reshaping the landscape. Moreover, the trend towards patient-centric care is fostering the growth of startups and initiatives that emphasize comprehensive pain relief and improved quality of life for cancer patients. As the market continues to evolve, competition intensifies, encouraging continuous innovation to address the multifaceted challenges of cancer pain management.

Cancer Pain Market Top Player’s Company Profiles

  • Pfizer (USA)
  • Johnson & Johnson (USA)
  • Purdue Pharma (USA)
  • Novartis (Switzerland)
  • Heron Therapeutics (USA)
  • Teva Pharmaceutical Industries (Israel)
  • Eli Lilly and Company (USA)
  • AstraZeneca (UK)
  • GlaxoSmithKline (UK)
  • Merck & Co., Inc. (USA0

Cancer Pain Market Recent Developments

  • In April 2023, Pfizer announced the approval of Lyrica (pregabalin) for the management of neuropathic pain associated with cancer.
  • In March 2023, the FDA approved Insys Therapeutics' Subsys (fentanyl) sublingual spray for the management of breakthrough pain in adults with cancer who are already receiving and are tolerant to opioid therapy.
  • In February 2023, the FDA granted breakthrough therapy designation to Ceregene's CTX-001 for the treatment of chronic pain associated with solid tumors.
  • In January 2023, the FDA approved the first non-opioid drug for the management of cancer pain.

Global Cancer Pain Key Market Trends

  • Personalized Pain Management: Increasing focus on individualized treatment approaches based on genetic and molecular profiles is shaping the direction of cancer pain management.
  • Multimodal Approaches: Combining different pain management techniques, such as pharmacological and non-pharmacological interventions, to address various aspects of pain is gaining traction.

Global Cancer Pain Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global cancer pain market analysis, the global cancer pain market encompasses a dynamic landscape driven by the increasing prevalence of cancer cases worldwide. This market focuses on providing effective pain management solutions for individuals undergoing cancer treatment or experiencing cancer-related pain. Factors such as advancements in medical technology, rising healthcare expenditures, and the growing geriatric population contribute to the expansion of this market. Pharmaceutical and healthcare companies, both established giants like Pfizer, Johnson & Johnson, and Novartis, as well as innovative startups like Heron Therapeutics, play a pivotal role in developing novel pain relief drugs, therapies, and drug delivery systems. The market's emphasis on personalized and patient-centric approaches, coupled with the integration of telemedicine and digital solutions, is transforming how cancer pain is managed. The shift towards non-opioid alternatives, multimodal strategies, and the integration of palliative care reflects a broader focus on enhancing the overall quality of life for cancer patients. As the market evolves, collaborations between pharmaceutical firms, medical institutions, and startups continue to shape a diverse landscape committed to alleviating the burden of cancer-related pain.

Report Metric Details
Market size value in 2021 USD 6.2 billion
Market size value in 2030 USD 10.12 billion
Growth Rate 5.6%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Drug
    • Opioids, Morphine, Fentanyl, Others, Non-opioids, Acetaminophen, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Nerve Blockers
  • Disease Indication
    • Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Pfizer (USA)
  • Johnson & Johnson (USA)
  • Purdue Pharma (USA)
  • Novartis (Switzerland)
  • Heron Therapeutics (USA)
  • Teva Pharmaceutical Industries (Israel)
  • Eli Lilly and Company (USA)
  • AstraZeneca (UK)
  • GlaxoSmithKline (UK)
  • Merck & Co., Inc. (USA0
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Cancer Pain Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Cancer Pain Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Cancer Pain Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Cancer Pain Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Cancer Pain Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Cancer Pain Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Cancer Pain Market size was valued at USD 6.2 billion in 2021 and is poised to grow from USD 6.55 billion in 2022 to USD 10.12 billion by 2030, growing at a CAGR of 5.6% in the forecast period (2023-2030).

The competitive landscape of the global cancer pain market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative solutions for effective pain management. Established players such as Pfizer, Johnson & Johnson, Purdue Pharma, and Novartis maintain a strong presence, leveraging their extensive research capabilities and product portfolios. These companies often collaborate with medical institutions to advance pain management technologies and therapies. 'Pfizer (USA)', 'Johnson & Johnson (USA)', 'Purdue Pharma (USA)', 'Novartis (Switzerland)', 'Heron Therapeutics (USA)', 'Teva Pharmaceutical Industries (Israel)', 'Eli Lilly and Company (USA)', 'AstraZeneca (UK)', 'GlaxoSmithKline (UK)', 'Merck & Co., Inc. (USA0'

Technological innovations in pain management techniques, drug delivery systems, and personalized treatments enhance the efficacy and accessibility of cancer pain management.

Personalized Pain Management: Increasing focus on individualized treatment approaches based on genetic and molecular profiles is shaping the direction of cancer pain management.

In 2022, North America played a pivotal role in the cancer pain market, capturing a substantial share, and this influential position is anticipated to persist throughout the forecast period. The region's continued prominence is underpinned by several factors including the escalating prevalence of cancer cases, continuous technological advancements in the healthcare sector, the convenient accessibility of pain management therapies, and the availability of top-tier chemotherapy treatment options. These factors collectively contribute to North America's stronghold in driving the growth of the cancer pain market.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cancer Pain Market

Product ID: SQMIG35J2075

$5,300
BUY NOW GET SAMPLE